As European Union leaders work through the consequences of their new trading arrangement with the US, they are confronting the bitter reality of just how far they have fallen.

The European Union and the United States have struck a deal imposing a 15% tariff on most EU exports, whereas Britain secured a 10% baseline tariff. Both agreements offer complex implications across industries such as pharmaceuticals,

"This is clearly the best deal we could get under very difficult circumstances," said Maroš Šefčovič, the European Commissioner for Trade. View on euronews